Cardiovascular Risk Evaluation through Heart Rate Variability (HRV) Analysis in Patients with Psoriasis before and after 12 Weeks of Etanercept Therapy: A Preliminary Prospective Study

Conclusion Our data suggest that treatment with etanercept in patients with moderate-to-severe psoriasis doesn ' t affect cardiovascular autonomic regulation, and subsequently the cardiovascular risk.
Source: Acta Dermatovenerologica Croatica - Category: Dermatology Source Type: research